| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
05-21-2007, 06:05 PM
|
#1 | |||
|
||||
|
Magnate
|
Today Elan Pharmaceuticals and Wyeth announced that they will begin phase III clinical trials on Bapineuzumab for Alzheimers disease based on the data seen at midpoint PII trials. The data seen has not been released and will not be until PII is concluded but this is almost 6 months before the PII trial is over!!
Whatever they saw MUST be GOOD!!!
__________________
I know the sound the river makes, by dawn, by night, by day. But can it stay me through tomorrows that find me far away? . I have this mental picture in my mind of you all, shaking bones and bells and charms, muttering prayers and voodoo curses, dancing around in a circle of salt, with leetle glasses and tiny bottles of cheer in the middle...myyyyyy friends! diagnosed 09/03/2004 scheduled to start Tysabri 03/05 Tysabri withdrawn from market 02/28/05 Copaxone 05/05-12/06 Tysabri returned to market 06/05/06 Found a new neuro 04/07 Tysabri 05/25/07-present Medical Marijuana legally 12/03/09 . Negative for JC virus antibodies! . I'm doing alright and making good grades, The future's so bright, I gotta wear shades! . |
|||
|
 Reply With Quote
|
| Reply |
|
|
Bapineuzumab
Linear Mode
